Ceredex Value Advisors LLC Sells 138,250 Shares of The Allstate Co. (NYSE:ALL)

Ceredex Value Advisors LLC reduced its holdings in shares of The Allstate Co. (NYSE:ALL - Free Report) by 48.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 148,700 shares of the insurance provider's stock after selling 138,250 shares during the period. Ceredex Value Advisors LLC owned about 0.06% of Allstate worth $28,338,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in ALL. Diversified Trust Co bought a new stake in shares of Allstate in the 1st quarter valued at approximately $226,000. Norden Group LLC acquired a new position in Allstate during the first quarter worth $641,000. Kovack Advisors Inc. bought a new position in shares of Allstate during the first quarter valued at $229,000. Retirement Systems of Alabama boosted its stake in shares of Allstate by 0.5% in the 1st quarter. Retirement Systems of Alabama now owns 57,937 shares of the insurance provider's stock valued at $10,024,000 after purchasing an additional 262 shares in the last quarter. Finally, J.W. Cole Advisors Inc. bought a new stake in shares of Allstate in the 1st quarter worth about $461,000. Institutional investors own 76.47% of the company's stock.

Insider Activity

In related news, EVP Elizabeth Brady sold 49,481 shares of Allstate stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the transaction, the executive vice president now owns 19,163 shares of the company's stock, valued at $3,431,901.67. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Allstate news, insider John E. Dugenske sold 36,367 shares of the stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares in the company, valued at $5,236,922.32. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Elizabeth Brady sold 49,481 shares of the firm's stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $179.09, for a total value of $8,861,552.29. Following the sale, the executive vice president now directly owns 19,163 shares in the company, valued at approximately $3,431,901.67. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 192,530 shares of company stock valued at $34,967,665 in the last ninety days. 1.80% of the stock is owned by insiders.

Allstate Trading Down 1.3 %

ALL stock traded down $2.37 during midday trading on Friday, reaching $184.15. The company's stock had a trading volume of 1,533,736 shares, compared to its average volume of 1,546,804. The business's 50-day simple moving average is $188.87 and its 200-day simple moving average is $175.23. The stock has a market cap of $48.62 billion, a PE ratio of 11.93, a price-to-earnings-growth ratio of 1.91 and a beta of 0.48. The Allstate Co. has a 52 week low of $127.93 and a 52 week high of $198.79. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.49.

Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping analysts' consensus estimates of $2.20 by $1.71. Allstate had a return on equity of 27.74% and a net margin of 6.77%. The business had revenue of $16.63 billion during the quarter, compared to analysts' expectations of $14.57 billion. During the same period in the previous year, the firm earned $0.81 earnings per share. The firm's quarterly revenue was up 14.7% compared to the same quarter last year. As a group, sell-side analysts expect that The Allstate Co. will post 14.16 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on ALL shares. Keefe, Bruyette & Woods boosted their price target on shares of Allstate from $199.00 to $208.00 and gave the company an "outperform" rating in a research report on Monday, August 12th. StockNews.com lowered Allstate from a "strong-buy" rating to a "buy" rating in a research report on Wednesday, August 21st. Piper Sandler lifted their price objective on Allstate from $188.00 to $196.00 and gave the company an "overweight" rating in a research report on Friday, August 16th. The Goldman Sachs Group boosted their price objective on Allstate from $199.00 to $204.00 and gave the stock a "buy" rating in a research note on Thursday, August 15th. Finally, Raymond James lifted their price target on Allstate from $205.00 to $220.00 and gave the company a "strong-buy" rating in a report on Friday, October 4th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $207.19.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.